Stay updated on Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Sign up to get notified when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice was added about NIH website updates and the use of “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.5%
    Check dated 2026-10-25T15:34:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T15:38:08.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T15:47:36.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the record history, and the previous entry v3.6.6 has been removed. This updates the page’s version history to reflect the latest administrative change.
    Difference
    0.1%
    Check dated 2026-09-20T20:30:13.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    An additional revision entry v3.6.6 was added to the record history. The previous v3.6.5 entry was removed, reflecting an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-08-30T21:55:35.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.4 to v3.6.5, reflecting a new site build rather than changes to the trial record.
    Difference
    0.1%
    Check dated 2026-08-09T11:06:51.000Z thumbnail image

Stay in the know with updates to Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.